On December 23, Gelonghui reported that Fuan Pharmaceutical (300194.SZ) stated on the investor interaction platform that the company has received approval for the anti-influenza drug Peramivir injection, but it is currently not in production or on sale.
福安药业(300194.SZ)：有抗流感类药物帕拉米韦注射液批文，但目前没有生产销售
Fuan Pharmaceutical (300194.SZ): has the approval for the Against Influenza drug Peramivir injection, but currently does not have production or sales.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated